6.
Hara J, Shankle W, Barrentine L, Curole M
. Novel Therapy of Hyperhomocysteinemia in Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementing Disorders. J Nutr Health Aging. 2016; 20(8):825-834.
DOI: 10.1007/s12603-016-0688-z.
View
7.
Kim H, Yoo J, Yoo S, Lee J, Chang W, Kim H
. Neuregulin-1 inhibits CoCl-induced upregulation of excitatory amino acid carrier 1 expression and oxidative stress in SH-SY5Y cells and the hippocampus of mice. Mol Brain. 2020; 13(1):153.
PMC: 7664014.
DOI: 10.1186/s13041-020-00686-2.
View
8.
Taylor M, Khathayer F, Ray S
. Quercetin and Sodium Butyrate Synergistically Increase Apoptosis in Rat C6 and Human T98G Glioblastoma Cells Through Inhibition of Autophagy. Neurochem Res. 2019; 44(7):1715-1725.
DOI: 10.1007/s11064-019-02802-8.
View
9.
Liu J, Wei A, Liu T, Ji X, Zhang Y, Yan F
. Icariin ameliorates glycolytic dysfunction in Alzheimer's disease models by activating the Wnt/β-catenin signaling pathway. FEBS J. 2024; 291(10):2221-2241.
DOI: 10.1111/febs.17099.
View
10.
Ma W, Wang S, Liu X, Tang F, Zhao P, Cheng K
. Protective effect of troxerutin and cerebroprotein hydrolysate injection on cerebral ischemia through inhibition of oxidative stress and promotion of angiogenesis in rats. Mol Med Rep. 2019; 19(4):3148-3158.
PMC: 6423560.
DOI: 10.3892/mmr.2019.9960.
View
11.
Wrobel-Biedrawa D, Grabowska K, Galanty A, Sobolewska D, Podolak I
. A Flavonoid on the Brain: Quercetin as a Potential Therapeutic Agent in Central Nervous System Disorders. Life (Basel). 2022; 12(4).
PMC: 9027262.
DOI: 10.3390/life12040591.
View
12.
Lan A, Xiao L, Yang Z, Yang C, Wang X, Chen P
. Interaction between ROS and p38MAPK contributes to chemical hypoxia-induced injuries in PC12 cells. Mol Med Rep. 2011; 5(1):250-5.
DOI: 10.3892/mmr.2011.623.
View
13.
Raghu G, Berk M, Campochiaro P, Jaeschke H, Marenzi G, Richeldi L
. The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress. Curr Neuropharmacol. 2020; 19(8):1202-1224.
PMC: 8719286.
DOI: 10.2174/1570159X19666201230144109.
View
14.
Esposito Z, Belli L, Toniolo S, Sancesario G, Bianconi C, Martorana A
. Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track?. CNS Neurosci Ther. 2013; 19(8):549-55.
PMC: 6493397.
DOI: 10.1111/cns.12095.
View
15.
Fiani B, Covarrubias C, Wong A, Doan T, Reardon T, Nikolaidis D
. Cerebrolysin for stroke, neurodegeneration, and traumatic brain injury: review of the literature and outcomes. Neurol Sci. 2021; 42(4):1345-1353.
DOI: 10.1007/s10072-021-05089-2.
View
16.
Ersoz M, Erdemir A, Derman S, Arasoglu T, Mansuroglu B
. Quercetin-loaded nanoparticles enhance cytotoxicity and antioxidant activity on C6 glioma cells. Pharm Dev Technol. 2020; 25(6):757-766.
DOI: 10.1080/10837450.2020.1740933.
View
17.
Bianchi M, Bardelli D, Chiu M, Bussolati O
. Changes in the expression of the glutamate transporter EAAT3/EAAC1 in health and disease. Cell Mol Life Sci. 2013; 71(11):2001-15.
PMC: 11113519.
DOI: 10.1007/s00018-013-1484-0.
View
18.
Yang E, Kim G, Kim J, Song K
. Protective effects of onion-derived quercetin on glutamate-mediated hippocampal neuronal cell death. Pharmacogn Mag. 2013; 9(36):302-8.
PMC: 3793334.
DOI: 10.4103/0973-1296.117824.
View
19.
Tardiolo G, Bramanti P, Mazzon E
. Overview on the Effects of -Acetylcysteine in Neurodegenerative Diseases. Molecules. 2018; 23(12).
PMC: 6320789.
DOI: 10.3390/molecules23123305.
View
20.
Zhao H, Wang R, Zhang Y, Liu Y, Huang Y
. Neuroprotective effects of troxerutin and cerebroprotein hydrolysate injection on the neurovascular unit in a rat model of Middle cerebral artery occlusion. Int J Neurosci. 2020; 131(3):264-278.
DOI: 10.1080/00207454.2020.1738431.
View